Document Detail

Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin.
MedLine Citation:
PMID:  7688059     Owner:  NLM     Status:  MEDLINE    
The effect of preoperative low-dose aspirin (1 mg/kg of body weight) and intraoperative low-dose aprotinin (2 million kallikrein inactivator units) treatment on perioperative blood loss and blood requirements in patients who undergo internal mammary artery bypass operations is unknown. Therefore, we retrospectively studied 75 matching patients who underwent internal mammary artery operations, and they were allocated to one of three groups: low-dose aspirin and aprotinin treatment (group 1, n = 25), low-dose aspirin treatment without aprotinin (group 2, n = 25), and neither aspirin nor aprotinin treatment (group 3, n = 25). Although the perioperative blood loss was similar, the blood requirements tended to be higher (p = 0.09) in the patients who were treated with aspirin (group 2) than in the control patients (group 3). When aprotinin was added to the priming solution in patients who were treated with aspirin (group 1), blood loss was significantly lower (p < 0.05) than that of group 2 patients but not of control patients. Blood requirements were significantly lower (p < 0.01) than those of patients in groups 2 and 3. Blood products were needed in 29%, 62%, and 75% of patients in groups 1, 2, and 3, respectively.
J P Schönberger; J J Bredée; W van Oeveren; A A van Zundert; M Verkroost; J Terwoorst; J H Bavinck; E Berreklouw; C R Wildevuur
Related Documents :
10735779 - Does intraoperative hetastarch administration increase blood loss and transfusion requi...
19204509 - Hboc-201 vasoactivity in a phase iii clinical trial in orthopedic surgery subjects--ext...
17766739 - Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery.
20563469 - The effects of modified ultrafiltration on pulmonary function and transfusion requireme...
10832659 - Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear c...
20869839 - Early changes of procalcitonin may advise about prognosis and appropriateness of antimi...
25286009 - Efficacy and safety of mcna in patients with non-muscle invasive bladder cancer at high...
20367089 - Root-coverage procedures for the treatment of localized recession-type defects: a cochr...
10735779 - Does intraoperative hetastarch administration increase blood loss and transfusion requi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  106     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1993-08-30     Completed Date:  1993-08-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  262-7     Citation Subset:  AIM; IM    
Department of Cardiopulmonary Surgery, Catharina Hospital, Eindhoven, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aprotinin / administration & dosage*
Aspirin / administration & dosage*
Blood Component Transfusion
Blood Loss, Surgical / prevention & control*
Drug Therapy, Combination
Internal Mammary-Coronary Artery Anastomosis*
Intraoperative Period
Middle Aged
Platelet Transfusion
Retrospective Studies
Reg. No./Substance:
50-78-2/Aspirin; 9087-70-1/Aprotinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Relation between the incorporation of 5-fluorouracil into liver carcinoma and normal tissue RNA at h...
Next Document:  Alpha-fetoprotein testing: opinions of parents of children with spina bifida.